LOS ANGELES, July 29, 2014 /PRNewswire/ — CannaMed Corp. (OTCBB: MDMJ), a company that provides both funding and financing alternatives and turnkey support services for the legal cannabis industry, is pleased to announce the addition of Ms. Vinisha Agnihotri as Vice President Finance.
Vinisha Agnihotri has a background in Natural Sciences and a degree in Economics from Rutgers University. She began her professional career in Private Wealth Management for an ultra-high net worth boutique called Graystone, wholly owned by Morgan Stanley. In 2004 she began a private consulting business to develop startup ventures across various sectors. Over the last 10 years Ms. Agnihotri has created a very resourceful global network, having assisted many key personalities with various projects and companies globally.
In her executive position with CannaMed, Ms. Agnihotri will serve the roles of VP Finance and Head of our Medical Research Committee. Amongst her other duties and responsibilities, Ms. Agnihotri is leading the Company’s banking and payment processing solutions, science initiatives and science community relations, and assisting our financing and fundraising efforts.
“We are pleased to announce the addition of Ms. Agnihotri as an executive to our growing management team,” states Mr. Jordan Shapiro, CEO of CannaMed. “Vinisha’s deep experience and background in banking, financing, and working with an international group of medical research leaders is especially important to us as we tackle the tremendous opportunity that lies ahead in the legal cannabis industry here in the United States. We look forward to her leadership and assistance.”
“I see tremendous synergies amalgamating my finance and biotech backgrounds with CannaMed’s growth initiatives. I’m proud to join such a prominent team in an exciting industry with a vast upside and iconic symbolism for generations ahead,” stated Ms. Agnihotri. “We are living in exciting times of innovations stemming back to nature, bringing me back to my familial roots of homeopathology instilled in me from my grandfather in India as a child, together with evolving liberations in the new age of prohibition.”
For more information on CannaMed Corp visit www.CannaMedCorp.com
About CannaMed Corporation
CannaMed Corporation, through wholly-owned subsidiaries, provide turnkey support solutions to the rapidly evolving and growing legal cannabis industry. CannaMed’s “seed to sale” key business services include:
- Loans to duly licensed industry participants seeking to acquire agricultural, commercial, and retail real estate.
- Point of Sale (POS) credit and debit card processing
- Turnkey dispensary solutions
- Compliance consulting
- Financial services
CannaMed’s team has over seven years of successful experience in the legal cannabis industry. CannaMed is excited to introduce its array of services to each new state that legalizes cannabis use.
Safe Harbor Statement
This release contains “forward-looking statements” that include information related to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the ability of CannaMed to secure appropriate funding to implement its business plan, the demand for CannaMed’s services, CannaMed’s ability to maintain customer and strategic business relationships, the regulation of legal cannabis on both state and federal levels, the impact of competitive products and pricing, growth in targeted markets, and other information that may be detailed from time-to- time in CannaMed’s filings with the United States Securities and Exchange Commission. CannaMed undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE CannaMed Corporation
CONTACT: (702) 751-8455, firstname.lastname@example.org, www.cannamedcorp.com